How to know when physicians are ready for genomic medicine

See allHide authors and affiliations

Science Translational Medicine  13 May 2015:
Vol. 7, Issue 287, pp. 287fs19
DOI: 10.1126/scitranslmed.aaa2401

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Enter the characters shown in the image.

Vertical Tabs

  • Forget physicians, are insurers ready for genomic medicine?

    Vassey, Korf and Green issue a welcome call to move beyond genetic exceptionalism and have non-geneticists begin practicing genomic medicine as it is relevant to their medical practices. Left unaddressed, however, is the massive barrier of financing. At the same time that press releases tout the $1000 genome, commercial clinical exomes retail for 10x that amount. Within the U.S., current policies by major insurance carriers e...

    Show More
    Competing Interests: None declared.

Navigate This Article